UBS’s NUVEEN EQUITY PREMIUM ADVANTAGE FUND JLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.38M Sell
181,962
-767
-0.4% -$10.3K ﹤0.01% 2754
2014
Q2
$2.43M Sell
182,729
-19,837
-10% -$261K ﹤0.01% 2693
2014
Q1
$2.57M Buy
202,566
+17,031
+9% +$217K ﹤0.01% 2529
2013
Q4
$2.35M Buy
185,535
+9,774
+6% +$121K ﹤0.01% 2653
2013
Q3
$2.13M Buy
175,761
+14,933
+9% +$186K ﹤0.01% 2506
2013
Q2
$1.99M Buy
+160,828
New +$2.03M ﹤0.01% 2556

Other funds holding JLA

UBS's JLA Position: Q3 2014 in Review

UBS reduced its NUVEEN EQUITY PREMIUM ADVANTAGE FUND (JLA) stake by 0.42% in Q3 2014, selling an estimated $10.3K and leaving 181,962 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2754.

UBS first reported a position in JLA in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.57M in Q1 2014. 48 funds tracked by Wall St. Rank hold JLA as of Q3 2014.

  • UBS held 181,962 shares of NUVEEN EQUITY PREMIUM ADVANTAGE FUND worth $2.38M as of Q3 2014.
  • UBS sold 767 NUVEEN EQUITY PREMIUM ADVANTAGE FUND shares in Q3 2014, an estimated $10.3K.
  • NUVEEN EQUITY PREMIUM ADVANTAGE FUND made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2754 holding.
  • UBS first reported a position in NUVEEN EQUITY PREMIUM ADVANTAGE FUND in Q2 2013 and has held it in 6 quarters since.
  • UBS's NUVEEN EQUITY PREMIUM ADVANTAGE FUND position peaked at $2.57M in Q1 2014.
  • 48 funds tracked by Wall St. Rank held NUVEEN EQUITY PREMIUM ADVANTAGE FUND as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.